Tag: Breast Cancer
-
Early-Onset Breast Cancer: Perlmutter Experts Explain Rising Rates in Younger Women
Understanding the Rise of Early-Onset Breast Cancer Breast cancer remains a leading health concern for women, and disturbing trends show younger patients being diagnosed at more advanced stages. At NYU Langone’s Perlmutter Cancer Center, experts stress that early-onset breast cancer—diagnoses in women under 50—requires tailored strategies in screening, prevention, and education. While 20- to 49-year-olds…
-
Perlmutter Cancer Center Experts Highlight Rising Early-Onset Breast Cancer and New Support Programs
H2: Rising tide of early-onset breast cancer in the United States P: Breast cancer remains the leading cause of cancer death among women aged 20 to 49 in the United States. At NYU Langone’s Perlmutter Cancer Center, doctors report that younger patients are being diagnosed at more advanced stages, underscoring the urgent need for improved…
-
Vitamin D Deficiency and Breast Cancer Risk: Could the Sunshine Vitamin Be a Hidden Player?
Could vitamin D influence breast cancer risk? Breast cancer remains the most commonly diagnosed cancer among women, with age, genetics, and lifestyle as well-established risk factors. In recent years, researchers have explored whether vitamin D — often called the “sunshine vitamin” — might also play a role in breast cancer risk. While findings are not…
-
Breast Cancer and Vitamin D: Could a Deficiency Be a Hidden Risk for Women?
What is vitamin D and why does it matter? Vitamin D, often called the sunshine vitamin, is produced in the skin after exposure to sunlight and is also found in a limited set of foods. It plays a key role in bone health by helping the body absorb calcium, but it also supports immune function…
-
Breast Cancer and Vitamin D: Could a Deficiency Be a Hidden Risk?
What is vitamin D and why does it matter? Vitamin D, often called the “sunshine vitamin,” is produced in the skin when exposed to sunlight and also comes from certain foods. It helps keep bones strong and supports immune function. For most adults, experts recommend about 600 IU (15 μg) daily, though needs can vary.…
-
Exercise Could Help Weight Management for Breast Cancer Survivors on Estrogen-Blocking Therapy
New insights on exercise and weight in breast cancer survivors Breast cancer survivors are navigating more than cancer treatment. A growing body of research suggests that exercise can play a crucial role in weight management for women undergoing long-term estrogen-blocking therapy, a common part of treatment plans. A recent study from the University of British…
-
Exercise as a Weight-Management Tool for Breast Cancer Survivors on Estrogen-Blocking Therapy
Exercise may aid weight management for breast cancer survivors on endocrine therapy New research from the University of British Columbia Okanagan (UBCO) offers promising insights into how exercise can support weight management for women who have survived breast cancer and are undergoing estrogen-blocking therapy. The study, led by Dr. Sarah Purcell of UBCO’s Southern Medical…
-
Hospitalization Spending on Cancers in Hunan, China (2017–2019): A Comprehensive Look at Costs and Determinants
Overview Cacing the economic burden of cancer requires looking beyond incidence and mortality to how hospitalization costs accumulate. A retrospective study using the CNHSNRS data from 2017–2019 in Hunan Province, China, quantified inpatient spending for all cancers, described the cost distribution across cancer sites and patient characteristics, and identified factors associated with higher per-admission costs.…
-
Exercise Helps Breast Cancer Survivors Manage Weight
New findings from UBC Okanagan highlight a surprising benefit of exercise for breast cancer survivors New research from the University of British Columbia (UBC) Okanagan adds a new dimension to how exercise benefits women who have survived breast cancer. While improving strength and cardiovascular endurance is well established, Dr. Sarah Purcell and her team report…
-
Hospitalization Costs for Cancers in Hunan, China (2017–2019): An In-Depth Look at Economic Burden and Driving Factors
Overview: The Economic Burden of Cancer in Hunan (2017–2019) The hospitalization expenditure for cancers in Hunan Province, China, from 2017 through 2019 reached US$2,490.36 million, illustrating a substantial economic burden on patients, insurers, and the health system. Across 872,309 cancer-related hospitalizations, medical insurance covered 64.10% of costs, while out-of-pocket payments accounted for 35.90%. These figures…